Endocrinology and metabolism after premature pubarche in girls

The prevalence of functional ovarian hyperandrogenism, hyperinsulinism and dyslipidaemia is increased in adolescent girls with a history of premature pubarche, defined as the appearance of pubic hair before the age of 8 years. The ovarian hyperandrogenism is characterized by clinical signs of androg...

Full description

Saved in:
Bibliographic Details
Published in:Acta Paediatrica Vol. 88; no. s433; pp. 73 - 77
Main Authors: Lbáñez, L, Potau, N, Zegher, F De
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01-12-1999
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The prevalence of functional ovarian hyperandrogenism, hyperinsulinism and dyslipidaemia is increased in adolescent girls with a history of premature pubarche, defined as the appearance of pubic hair before the age of 8 years. The ovarian hyperandrogenism is characterized by clinical signs of androgen excess and an exaggerated ovarian 17‐hydroxyprogesterone response to gonadotrophin‐releasing hormone aganist stimulation. The hyperinsulinism and dyslipidaemia are detectable before and during pubertal development, and they are commonly accompanied by low serum levels of insulin‐like growth factor binding protein‐1 (IGEBP‐1) and sex hormone binding globulin, and by an increased prevalence of anovulation from late adolescence onwards. In girls, premature pubarche, hyperinsulinism, low serum levels of IGFBP‐1 dyslipidaemia, anovulation and hyperandrogenism (or various combinations of these conditions) have been related to reduced fetal growth, indicating that these constellations or sequences may have a prenatal origin. These findings suggest that premature pubarche in girls should no longer be regarded as meaely a normal variant of development, but rather as a childhood marker pointing to an increased risk of a polyendocrine‐metabolic disorder of prenatal origin.
AbstractList The prevalence of functional ovarian hyperandrogenism, hyperinsulinism and dyslipidaemia is increased in adolescent girls with a history of premature pubarche, defined as the appearance of pubic hair before the age of 8 years. The ovarian hyperandrogenism is characterized by clinical signs of androgen excess and an exaggerated ovarian 17‐hydroxyprogesterone response to gonadotrophin‐releasing hormone aganist stimulation. The hyperinsulinism and dyslipidaemia are detectable before and during pubertal development, and they are commonly accompanied by low serum levels of insulin‐like growth factor binding protein‐1 (IGEBP‐1) and sex hormone binding globulin, and by an increased prevalence of anovulation from late adolescence onwards. In girls, premature pubarche, hyperinsulinism, low serum levels of IGFBP‐1 dyslipidaemia, anovulation and hyperandrogenism (or various combinations of these conditions) have been related to reduced fetal growth, indicating that these constellations or sequences may have a prenatal origin. These findings suggest that premature pubarche in girls should no longer be regarded as meaely a normal variant of development, but rather as a childhood marker pointing to an increased risk of a polyendocrine‐metabolic disorder of prenatal origin.
The prevalence of functional ovarian hyperandrogenism, hyperinsulinism and dyslipidaemia is increased in adolescent girls with a history of premature pubarche, defined as the appearance of pubic hair before the age of 8 years. The ovarian hyperandrogenism is characterized by clinical signs of androgen excess and an exaggerated ovarian 17‐hydroxyprogesterone response to gonadotrophin‐releasing hormone aganist stimulation. The hyperinsulinism and dyslipidaemia are detectable before and during pubertal development, and they are commonly accompanied by low serum levels of insulin‐like growth factor binding protein‐1 ( IGEBP‐1 ) and sex hormone binding globulin, and by an increased prevalence of anovulation from late adolescence onwards. In girls, premature pubarche, hyperinsulinism, low serum levels of IGFBP‐1 dyslipidaemia, anovulation and hyperandrogenism (or various combinations of these conditions) have been related to reduced fetal growth, indicating that these constellations or sequences may have a prenatal origin. These findings suggest that premature pubarche in girls should no longer be regarded as meaely a normal variant of development, but rather as a childhood marker pointing to an increased risk of a polyendocrine‐metabolic disorder of prenatal origin.
The prevalence of functional ovarian hyperandrogenism, hyperinsulinism and dyslipidaemia is increased in adolescent girls with a history of premature pubarche, defined as the appearance of pubic hair before the age of 8 years. The ovarian hyperandrogenism is characterized by clinical signs of androgen excess and an exaggerated ovarian 17-hydroxyprogesterone response to gonadotrophin-releasing hormone agonist stimulation. The hyperinsulinism and dyslipidaemia are detectable before and during pubertal development, and they are commonly accompanied by low serum levels of insulin-like growth factor binding protein-1 (IGFBP-1) and sex hormone binding globulin, and by an increased prevalence of anovulation from late adolescence onwards. In girls, premature pubarche, hyperinsulinism, low serum levels of IGFBP-1, dyslipidaemia, anovulation and hyperandrogenism (or various combinations of these conditions) have been related to reduced fetal growth, indicating that these constellations or sequences may have a prenatal origin. These findings suggest that premature pubarche in girls should no longer be regarded as merely a normal variant of development, but rather as a childhood marker pointing to an increased risk of a polyendocrine-metabolic disorder of prenatal origin.
Author Lbáñez, L
Potau, N
Zegher, F De
Author_xml – sequence: 1
  givenname: L
  surname: Lbáñez
  fullname: Lbáñez, L
  email: lourdes.ibanez@deinfo.es
  organization: Hospital Sant Joan de Déu University of Barcelona
– sequence: 2
  givenname: N
  surname: Potau
  fullname: Potau, N
  organization: Hospital Materno-Infantil Vall d'Hebron Autonomous University of Barcelona, Spain
– sequence: 3
  givenname: F De
  surname: Zegher
  fullname: Zegher, F De
  organization: Department of Pediatrics University of Leuven, Belgium
BackLink https://www.ncbi.nlm.nih.gov/pubmed/10626549$$D View this record in MEDLINE/PubMed
BookMark eNqVkFtLw0AQhRep2Iv-BQm-J-49WUGh1FrFoiJVH5dJsltTcymbFNt_b0qk-Oq8zMOc7zDnDFGvrEqD0AXBAWnnchUQKYhPKQ0DopQKmphwjsNge4QGh1MPDXCEmS-oYH00rOsVxpQpLk9Qn2BJpeBqgG6mZVolLiurvFruPChTrzANxFWe1YUHtjHOWztTQLNxxltvYnDJp_Gy0ltmLq9P0bGFvDZnv3uE3u6mi8m9P3-ePUzGcz9p_2K-DSFWnAqBbaoiHNqY2jiSEZYQJYkCClYwYDbmDBMOKk65UVJFDABzAMFG6KrzTVxV185YvXZZAW6nCdb7UvRK75PrfXK9L0X_lqK3LXzewe37hUn_oF0LreC6E3xnudn9w1qPX8Yha3m_47O6MdsDD-5Ly5CFQn88zXR4Kx_p6_tcL9gP7NiDBA
CitedBy_id crossref_primary_10_1210_er_2004_0004
crossref_primary_10_1017_S002193200999054X
crossref_primary_10_1590_S0004_27302006000500010
crossref_primary_10_1111_j_1749_6632_2008_03675_x
crossref_primary_10_1186_1687_9856_2011_9
crossref_primary_10_1046_j_1365_2265_2002_01579_x
crossref_primary_10_1007_s00404_013_3095_2
crossref_primary_10_1542_peds_2007_1813G
crossref_primary_10_4274_jcrpe_galenos_2022_2022_1_1
Cites_doi 10.1210/jc.74.2.254
10.1210/jc.81.8.2854
10.1007/BF03350781
10.1056/NEJM199604113341504
10.1056/NEJM199207163270304
10.1210/jc.84.8.2691
10.1056/NEJM199608293350902
10.1210/jc.81.3.1237
10.1210/jc.82.12.4075
10.1210/er.16.3.322
10.1210/jc.82.5.1390
10.1210/jc.76.2.273
10.1080/03014469700005202
10.1210/jcem-62-5-904
10.1210/jc.81.9.3299
10.1210/jc.82.7.2283
10.1159/000183950
10.1210/jc.81.3.878
10.1210/jc.80.10.2966
10.1210/jc.79.6.1778
10.1159/000184592
10.1007/s001250051030
10.1056/NEJM198903023200904
10.1210/jcem.81.3.8772576
10.1016/S0015-0282(16)57970-9
10.1016/S1043-2760(98)00014-9
10.1203/00006450-199909000-00012
10.1210/jc.81.11.3892
10.1210/endo-123-2-733
10.1210/jc.76.6.1599
10.1210/jcem.83.10.5205
10.1016/S0002-9378(11)90605-X
10.1093/oxfordjournals.aje.a113639
10.1210/jcem-66-2-266
10.1210/jc.76.5.1241
ContentType Journal Article
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.1111/j.1651-2227.1999.tb14407.x
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1651-2227
EndPage 77
ExternalDocumentID 10_1111_j_1651_2227_1999_tb14407_x
10626549
APA73
ark_67375_WNG_7D6K2RVL_T
Genre article
Journal Article
GroupedDBID .55
.GA
.GJ
1OC
3O-
51W
51X
52N
52O
52P
52R
52T
52W
52X
53G
5GY
5HH
5LA
5RE
66C
7PT
930
A01
A03
AAWTL
ABDBF
ACGFS
AI.
ALMA_UNASSIGNED_HOLDINGS
BSCLL
BY8
EAD
EAP
EAS
EBC
EBD
EBX
EMB
EMK
EMOBN
EPT
ESX
F5P
LP6
LP7
N9D
P4B
P4D
Q~Q
SV3
TUS
VH1
WQJ
WRC
WXI
X7M
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
ID FETCH-LOGICAL-c4073-f7ab942550fd9807fb2fb86806a8cc9a2af53a3fb43014a9bd4e96983aa04aa53
IEDL.DBID 33P
ISSN 0803-5253
0803-5326
IngestDate Thu Nov 21 22:36:13 EST 2024
Sat Sep 28 07:45:26 EDT 2024
Sat Aug 24 00:59:15 EDT 2024
Wed Oct 30 09:52:40 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue s433
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4073-f7ab942550fd9807fb2fb86806a8cc9a2af53a3fb43014a9bd4e96983aa04aa53
Notes istex:A5672CBD86237A649293BB3DFEC0E432FABF15ED
ark:/67375/WNG-7D6K2RVL-T
ArticleID:APA73
PMID 10626549
PageCount 5
ParticipantIDs crossref_primary_10_1111_j_1651_2227_1999_tb14407_x
pubmed_primary_10626549
wiley_primary_10_1111_j_1651_2227_1999_tb14407_x_APA73
istex_primary_ark_67375_WNG_7D6K2RVL_T
PublicationCentury 1900
PublicationDate December 1999
PublicationDateYYYYMMDD 1999-12-01
PublicationDate_xml – month: 12
  year: 1999
  text: December 1999
PublicationDecade 1990
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Norway
PublicationTitle Acta Paediatrica
PublicationTitleAlternate Acta Paediatr Suppl
PublicationYear 1999
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL. Plasma insulin and lipoprotein concentrations: an atherogenic association Am J Epidemiol 1983;118:326-37.
Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-7.
De la Puente ML, Canela J, Alvarez J, Salleras L, Vicens-Calvet E. Cross-sectional growth study of the child and adolescent population of Catalonia (Spain). Ann Hum Biol 1997;24:435-52.
Ibáñez L, Potau N, Carrascosa A. Insulin resistance, premature adrenarche, and a risk of the polycystic ovary syndrome (PCOS). TEM 1998;9:72-7.
Nestler JE, Jakubowicz DJ. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17α activity and serum androgens. J Clin Endocrinol Metab 1997;82:4075-9.
Ibáñez L, Potau N, De Zegher F. Precocious pubarche, dyslipidemia, and low IGF binding protein-1 in girls: relation to reduced prenatal growth. Pediatr Res 1999;46:320-2.
Rosenfield RL. Normal and almost normal variations in pubertal development. Premature pubarche and premature thelarche revisited. Horm Res 1994; 41 (Suppl 2): 7-13.
Ibáñez L, De Zegher F, Potau N. Premature pubarche, ovarian hyperinsulinism, hyperandrogenism and the polycystic ovary syndrome: from a complex constellation ato a simple sequence of prenatal onset. J Endocrinol Invest 1998;21:558-66.
Ibáñez L, Patau N, Francois I, De Zegher F. Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998;83:3558-62.
Ibáñez L, Potau N, De Zegher F. Anovulation after precocious pubarche: early markers and time course in adolescence. J Clin Endocrinol Metab 1999;84:2691-95.
O'Meara NM, Blackman JD, Ehrmann DA, Barnes RB, Jaspan JB, Rosenfield RL, et al. Defects in β-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993;76:1241-7.
Ibáñez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinyé M, et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyuperandrogenism. J Clin Endocrinol Metab 1993;76:1599-1603.
Ibáñez L, Potau N, Georgopoulos N, Prat N, Gussinyé M, Carrascosa A. Growth hormone, insulin-like growth factor-I axis, and insulin secretion in hyperandrogenic adolescents. Fertil Steril 1995;64:1113-9.
Dunaif A, Scott D, Finegood D, Quntana B, Whitcomb R. The insulin sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996;81:3299-306.
Mesiano S, Katz LS, Lee JY, Jaffe RB. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen production. J Clin Endocrinol Metab 1997;82:1390-6.
Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996;335:617-23.
Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 1992;327:157-62.
Ibáñez L, Virdis R, Potau N, Zampolli M, Ghizzoni L, Albisu MA, et al. Natural history of premature pubarche: an auxological study. J Clin Endocrinol Metab 1992;74:254-7.
Apter D, Bützow T, Laughlin GA, Yen SSC. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab 1995;80:2966-73.
Arslanian S, Suprasongsin C. Insulin sensitivity, lipids, and body compostion in childhood: is "Syndrome X" present J Clin Endocrinol Metab 1996;81:1058-62.
Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995;16:322-53.
Ibáñez L, Patau N, Zampolli M, Riqué S, Saenger P, Carrascosa A. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1997;82:2283-8.
Nestler JE. Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? (editorial). J Clin Endocrinol Metab 1993;76:273-4.
Ibáñez L, Bonnin MR, Zampolli M, Prat N, Alia PJ, Navarro MA Usefulness of an ACTH test in the diagnosis of nonclassical 21-hydroxylase deficiency among childredn presenting with premature pubarche. Horm Res 1995;44:51-6.
Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SSC. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 1996;81:2854-64.
Wild RA, Alaupovic P, Parker IJ. Lipid and lipoprotein abnormalities in hirsute women. I. The association with insulin resistance. Am J Obstet Gynecol 1992;166:1191-7.
Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hperandrogenism. J Clin Endocrinol Metab 1986;62:904-10.
Suikkari AM, Koivisto VA, Rutanen EM, Yki-Järvinen H, Karonen SL, Seppäla M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding protein. J Clin Endocrinol Metab 1988;66:266-72.
Barnes RB, Rosenfield RL, Burnstein S, Ehrmann DA. Pituitaryovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med 1989;320:559-67.
Rosenfield RL. Evidence that idiopathic functional adrenal hyperandrogenism is caussed by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may; be involved (editorial). J Clin Endocrinol Metab 1996;81:878-80.
Ibáñez L, Potau N, Chacón P, Pascual C, Carrascosa A. Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 1998;41:1057-63.
Cara JF, Rosenfield RL. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology 1988;123:733-9.
Després JP. The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease CMAJ 1993;148:1339-40.
Ibáñez L, Potau N, Zampolli M, Prat N, Gussinye M, Saenger P, et al. Source localization of androgen excess in adolescent girls. J Clin Endocrinol Metab 1994;79:1778-84.
Ibáñez L, Patau N, Zampolli M, Prat N, Virdis R, Vicens-Calvet E, et al. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1996;81:1237-43.
L'Allemand D, Penhoat A, Lebrethon MC, Ardevol R, Baehr V, Oelkers W, et al. Insulin-like growth factors enhanced steroidogenic enzyme and corticotopin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsivencess in cultured human adrenocortical cells. J Clin Endocrinol Metab 1996; 81: 3892-7.
1997; 82
1995; 16
1992; 166
1997; 24
1999; 46
1997
1992; 327
1988; 123
1999; 84
1998; 83
1998; 41
1998; 21
1993; 148
1994; 41
1992; 74
1983; 118
1995; 64
1995; 80
1986; 62
1993; 76
1995; 44
1989; 320
1988; 66
1994; 79
1996; 81
1996; 335
1996; 334
1998; 9
e_1_2_1_22_2
e_1_2_1_23_2
e_1_2_1_20_2
e_1_2_1_21_2
e_1_2_1_26_2
e_1_2_1_27_2
e_1_2_1_24_2
e_1_2_1_25_2
Després JP (e_1_2_1_30_2) 1993; 148
Arslanian S (e_1_2_1_35_2) 1996; 81
e_1_2_1_28_2
e_1_2_1_29_2
Ibáñez L (e_1_2_1_36_2) 1998; 83
Ibáñez L (e_1_2_1_4_2) 1997
e_1_2_1_6_2
e_1_2_1_7_2
e_1_2_1_5_2
e_1_2_1_2_2
e_1_2_1_11_2
e_1_2_1_34_2
e_1_2_1_3_2
e_1_2_1_12_2
e_1_2_1_33_2
e_1_2_1_32_2
e_1_2_1_10_2
e_1_2_1_31_2
e_1_2_1_15_2
e_1_2_1_38_2
e_1_2_1_16_2
e_1_2_1_37_2
e_1_2_1_13_2
e_1_2_1_14_2
e_1_2_1_19_2
e_1_2_1_8_2
e_1_2_1_17_2
e_1_2_1_9_2
e_1_2_1_18_2
References_xml – volume: 82
  start-page: 4075
  year: 1997
  end-page: 9
  article-title: Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17α activity and serum androgens
  publication-title: J Clin Endocrinol Metab
– volume: 166
  start-page: 1191
  year: 1992
  end-page: 7
  article-title: Lipid and lipoprotein abnormalities in hirsute women. I. The association with insulin resistance
  publication-title: Am J Obstet Gynecol
– volume: 81
  start-page: 878
  year: 1996
  end-page: 80
  article-title: Evidence that idiopathic functional adrenal hyperandrogenism is caussed by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may; be involved (editorial)
  publication-title: J Clin Endocrinol Metab
– volume: 41
  start-page: 1057
  year: 1998
  end-page: 63
  article-title: Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche
  publication-title: Diabetologia
– volume: 21
  start-page: 558
  year: 1998
  end-page: 66
  article-title: Premature pubarche, ovarian hyperinsulinism, hyperandrogenism and the polycystic ovary syndrome: from a complex constellation ato a simple sequence of prenatal onset
  publication-title: J Endocrinol Invest
– volume: 64
  start-page: 1113
  year: 1995
  end-page: 9
  article-title: Growth hormone, insulin‐like growth factor‐I axis, and insulin secretion in hyperandrogenic adolescents
  publication-title: Fertil Steril
– volume: 66
  start-page: 266
  year: 1988
  end-page: 72
  article-title: Insulin regulates the serum levels of low molecular weight insulin‐like growth factor binding protein
  publication-title: J Clin Endocrinol Metab
– volume: 80
  start-page: 2966
  year: 1995
  end-page: 73
  article-title: Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism
  publication-title: J Clin Endocrinol Metab
– volume: 82
  start-page: 2283
  year: 1997
  end-page: 8
  article-title: Hyperinsulinemia and decreased insulin‐like growth factor‐binding protein‐1 are common features in prepubertal and pubertal girls with a history of premature pubarche
  publication-title: J Clin Endocrinol Metab
– volume: 81
  start-page: 3892
  year: 1996
  end-page: 7
  article-title: Insulin‐like growth factors enhanced steroidogenic enzyme and corticotopin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsivencess in cultured human adrenocortical cells
  publication-title: J Clin Endocrinol Metab
– volume: 74
  start-page: 254
  year: 1992
  end-page: 7
  article-title: Natural history of premature pubarche: an auxological study
  publication-title: J Clin Endocrinol Metab
– volume: 41
  start-page: 7
  issue: Suppl 2
  year: 1994
  end-page: 13
  article-title: Normal and almost normal variations in pubertal development. Premature pubarche and premature thelarche revisited
  publication-title: Horm Res
– volume: 83
  start-page: 3558
  year: 1998
  end-page: 62
  article-title: Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth
  publication-title: J Clin Endocrinol Metab
– volume: 46
  start-page: 320
  year: 1999
  end-page: 2
  article-title: Precocious pubarche, dyslipidemia, and low IGF binding protein‐1 in girls: relation to reduced prenatal growth
  publication-title: Pediatr Res
– volume: 118
  start-page: 326
  year: 1983
  end-page: 37
  article-title: Plasma insulin and lipoprotein concentrations: an atherogenic association
  publication-title: Am J Epidemiol
– volume: 76
  start-page: 1599
  year: 1993
  end-page: 1603
  article-title: Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyuperandrogenism
  publication-title: J Clin Endocrinol Metab
– volume: 16
  start-page: 322
  year: 1995
  end-page: 53
  article-title: Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion
  publication-title: Endocr Rev
– volume: 81
  start-page: 2854
  year: 1996
  end-page: 64
  article-title: Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features
  publication-title: J Clin Endocrinol Metab
– volume: 148
  start-page: 1339
  year: 1993
  end-page: 40
  article-title: The insulin resistance‐dyslipidemia syndrome: the most prevalent cause of coronary artery disease
  publication-title: CMAJ
– volume: 335
  start-page: 617
  year: 1996
  end-page: 23
  article-title: Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome
  publication-title: N Engl J Med
– volume: 81
  start-page: 3299
  year: 1996
  end-page: 306
  article-title: The insulin sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome
  publication-title: J Clin Endocrinol Metab
– volume: 24
  start-page: 435
  year: 1997
  end-page: 52
  article-title: Cross‐sectional growth study of the child and adolescent population of Catalonia (Spain)
  publication-title: Ann Hum Biol
– volume: 327
  start-page: 157
  year: 1992
  end-page: 62
  article-title: Detection of functional ovarian hyperandrogenism in women with androgen excess
  publication-title: N Engl J Med
– volume: 76
  start-page: 273
  year: 1993
  end-page: 4
  article-title: Sex hormone‐binding globulin: a marker for hyperinsulinemia and/or insulin resistance? (editorial)
  publication-title: J Clin Endocrinol Metab
– volume: 82
  start-page: 1390
  year: 1997
  end-page: 6
  article-title: Insulin‐like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen production
  publication-title: J Clin Endocrinol Metab
– volume: 9
  start-page: 72
  year: 1998
  end-page: 7
  article-title: Insulin resistance, premature adrenarche, and a risk of the polycystic ovary syndrome (PCOS)
  publication-title: TEM
– volume: 123
  start-page: 733
  year: 1988
  end-page: 9
  article-title: Insulin‐like growth factor I and insulin potentiate luteinizing hormone‐induced androgen synthesis by rat ovarian thecal‐interstitial cells
  publication-title: Endocrinology
– volume: 81
  start-page: 1237
  year: 1996
  end-page: 43
  article-title: Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism
  publication-title: J Clin Endocrinol Metab
– volume: 79
  start-page: 1778
  year: 1994
  end-page: 84
  article-title: Source localization of androgen excess in adolescent girls
  publication-title: J Clin Endocrinol Metab
– volume: 334
  start-page: 952
  year: 1996
  end-page: 7
  article-title: Hyperinsulinemia as an independent risk factor for ischemic heart disease
  publication-title: N Engl J Med
– volume: 76
  start-page: 1241
  year: 1993
  end-page: 7
  article-title: Defects in β‐cell function in functional ovarian hyperandrogenism
  publication-title: J Clin Endocrinol Metab
– volume: 81
  start-page: 1058
  year: 1996
  end-page: 62
  article-title: Insulin sensitivity, lipids, and body compostion in childhood: is “Syndrome X” present
  publication-title: J Clin Endocrinol Metab
– start-page: 73
  year: 1997
  end-page: 84
– volume: 44
  start-page: 51
  year: 1995
  end-page: 6
  article-title: Usefulness of an ACTH test in the diagnosis of nonclassical 21‐hydroxylase deficiency among childredn presenting with premature pubarche
  publication-title: Horm Res
– volume: 62
  start-page: 904
  year: 1986
  end-page: 10
  article-title: Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hperandrogenism
  publication-title: J Clin Endocrinol Metab
– volume: 320
  start-page: 559
  year: 1989
  end-page: 67
  article-title: Pituitaryovarian responses to nafarelin testing in the polycystic ovary syndrome
  publication-title: N Engl J Med
– volume: 84
  start-page: 2691
  year: 1999
  end-page: 95
  article-title: Anovulation after precocious pubarche: early markers and time course in adolescence
  publication-title: J Clin Endocrinol Metab
– ident: e_1_2_1_2_2
  doi: 10.1210/jc.74.2.254
– ident: e_1_2_1_16_2
  doi: 10.1210/jc.81.8.2854
– ident: e_1_2_1_37_2
  doi: 10.1007/BF03350781
– ident: e_1_2_1_31_2
  doi: 10.1056/NEJM199604113341504
– ident: e_1_2_1_13_2
  doi: 10.1056/NEJM199207163270304
– ident: e_1_2_1_7_2
  doi: 10.1210/jc.84.8.2691
– ident: e_1_2_1_24_2
  doi: 10.1056/NEJM199608293350902
– ident: e_1_2_1_28_2
  doi: 10.1210/jc.81.3.1237
– ident: e_1_2_1_25_2
  doi: 10.1210/jc.82.12.4075
– ident: e_1_2_1_9_2
  doi: 10.1210/er.16.3.322
– ident: e_1_2_1_21_2
  doi: 10.1210/jc.82.5.1390
– ident: e_1_2_1_23_2
  doi: 10.1210/jc.76.2.273
– ident: e_1_2_1_6_2
  doi: 10.1080/03014469700005202
– ident: e_1_2_1_18_2
  doi: 10.1210/jcem-62-5-904
– ident: e_1_2_1_26_2
  doi: 10.1210/jc.81.9.3299
– ident: e_1_2_1_27_2
  doi: 10.1210/jc.82.7.2283
– ident: e_1_2_1_3_2
  doi: 10.1159/000183950
– ident: e_1_2_1_17_2
  doi: 10.1210/jc.81.3.878
– ident: e_1_2_1_15_2
  doi: 10.1210/jc.80.10.2966
– ident: e_1_2_1_11_2
  doi: 10.1210/jc.79.6.1778
– ident: e_1_2_1_5_2
  doi: 10.1159/000184592
– ident: e_1_2_1_32_2
  doi: 10.1007/s001250051030
– ident: e_1_2_1_10_2
  doi: 10.1056/NEJM198903023200904
– volume: 81
  start-page: 1058
  year: 1996
  ident: e_1_2_1_35_2
  article-title: Insulin sensitivity, lipids, and body compostion in childhood: is “Syndrome X” present
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.81.3.8772576
  contributor:
    fullname: Arslanian S
– ident: e_1_2_1_12_2
  doi: 10.1016/S0015-0282(16)57970-9
– ident: e_1_2_1_34_2
  doi: 10.1016/S1043-2760(98)00014-9
– ident: e_1_2_1_38_2
  doi: 10.1203/00006450-199909000-00012
– ident: e_1_2_1_20_2
  doi: 10.1210/jc.81.11.3892
– ident: e_1_2_1_19_2
  doi: 10.1210/endo-123-2-733
– ident: e_1_2_1_8_2
  doi: 10.1210/jc.76.6.1599
– volume: 83
  start-page: 3558
  year: 1998
  ident: e_1_2_1_36_2
  article-title: Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.83.10.5205
  contributor:
    fullname: Ibáñez L
– ident: e_1_2_1_33_2
  doi: 10.1016/S0002-9378(11)90605-X
– ident: e_1_2_1_29_2
  doi: 10.1093/oxfordjournals.aje.a113639
– start-page: 73
  volume-title: Androgen excess disorders in women
  year: 1997
  ident: e_1_2_1_4_2
  contributor:
    fullname: Ibáñez L
– ident: e_1_2_1_22_2
  doi: 10.1210/jcem-66-2-266
– ident: e_1_2_1_14_2
  doi: 10.1210/jc.76.5.1241
– volume: 148
  start-page: 1339
  year: 1993
  ident: e_1_2_1_30_2
  article-title: The insulin resistance‐dyslipidemia syndrome: the most prevalent cause of coronary artery disease
  publication-title: CMAJ
  contributor:
    fullname: Després JP
SSID ssj0023946
ssj0004374
Score 1.6913972
Snippet The prevalence of functional ovarian hyperandrogenism, hyperinsulinism and dyslipidaemia is increased in adolescent girls with a history of premature pubarche,...
SourceID crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 73
SubjectTerms Birth Weight
Child
Female
Functional ovarian hyperandrogenism
Humans
hyperinsulinism
Insulin Resistance - physiology
Insulin-Like Growth Factor I - physiology
low birth weight
Ovary - physiopathology
Polycystic Ovary Syndrome - physiopathology
premature pubarche
Puberty, Precocious - metabolism
Puberty, Precocious - physiopathology
Title Endocrinology and metabolism after premature pubarche in girls
URI https://api.istex.fr/ark:/67375/WNG-7D6K2RVL-T/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1651-2227.1999.tb14407.x
https://www.ncbi.nlm.nih.gov/pubmed/10626549
Volume 88
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3JTsMwELWgSIgL-1I2-YC4BSWxHdsXpKoLSLQVgrLcLDuJUUWbVmkr9fOxnQDtgQOIS262kxmPZ17s9wzAhSQhVgmPPBwkBqBEyvdYgKgX6FCbfEt0jC05-faRdl9Zo2llctqfXJhCH-Lrh5uNDLde2wCXarIc5BEJPMvltJQ7fjVVdqOSXtmK0sAGx-dA998kSWQLnRKKIV5QeJiPDBQjqJQjLc_4_NDvUupas16YL-StxdrWJafW1v9-1jbYLItUWCtm1Q5YSbNdsN4pt-H3wHUzS0ZmuSn-yUOZJXCYTs10GvQnQ-iuHYfj3KrBzvIUmld3iiGwn8G3fj6Y7IOnVrNXv_XKixi82IyMPE2l4ia4ia8TznyqVagVi5gfSRbHXIZSEySRVtgCNMlVglMecYak9LGUBB2ASjbK0iMAFcUGEPqximmMuamZFVaExyRlgQwpCasAfdpYjAu9DbGAU4xphDWNsKYRpWnEvAounTu-msj83Z5Yo0S8dG8EbUR34cNzW_Sq4LDw10LnBtIZkFwFkXPLL0YVtfsaRcd_bXgCNpwGhDsbcwoq03yWnoHVSTI7dzPXPJv1zgf7_ul_
link.rule.ids 315,782,786,1408,27933,27934,46064,46488
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NT9swFH8aRRq7sAFjlMHmA-IWlMTfF6QKCp1oK8QK282ykxhVQKjSVuLPx3YClAOHof0BtpP34fd-9vs9A-xpmhKTSxaRJHcAhZk4EgnmUWJT6-IttRnx5OTebz78K467vk3O4IkLU_eHeD5w854R9mvv4P5A-rWXM5pEnszpOXfyYGb8TSU_cCnlMmHOMj2jA5-_0CSxT3UaMIZlTeIRMXZgjOKmIWlT5fPGxK-C17LXw8NC5FrMbkN4Ovn8n3_sC6w2eSrq1Ia1Bh-Kch0-Dpqb-A047Jb5vdtx6mN5pMsc3RUzZ1G34-kdCi-Po0nlG8LOqwK5bw9NQ9C4RNfj6nb6FS5PuqOjXtS8xRBlbmUcWa6NdP5NY5tLEXNrUmsEEzHTIsukTrWlWGNriMdoWpqcFJJJgbWOidYUb0KrvC-LLUCGE4cJ48xkPCPSpc2GGCozWohEp5ymbcBPQlaTuuWGWoAqTjTKi0Z50ahGNOqhDftBH89DdHXji9Y4VX-Gp4ofs7P04qqvRm34VitsYXKH6hxObgMLevmHVVXnvMPx9nsH_oSV3mjQV_1fw7Pv8Cm0hAilMjvQmlXzYheWpvn8RzDjR1sW7LE
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9owFH_ailTt0q-tHV3b-VDtliqJ7di-TEIFygRDqO223iw7iSs0SFEAiT-_thNaOOywaX-A7eR9-L2f_d7PAJeKxkRnIglIlFmAkugw4BFmQWRiY-MtNSlxzcm9OzZ84O2Oo8kZrHthKn6IlwM35xl-v3YOPsvMtpMnNApcL6druRNXC-0uKtmVzSgbxObljkkf49FrlyR2mU6NxbCoenh4iC0Wo7jmI62LfP4w8Vbsajg1rDYC12Zy66NTd____tcB7NVZKmpVZnUIb_LiCHa_1_fw7-Frp8ie7H5THcojVWRomi-sPU3G8yny746jWenoYJdljuyne8oQNC7Q47iczD_Aj27n_roX1C8xBKldGQeGKS2sd9PQZIKHzOjYaJ7wMFE8TYWKlaFYYaOJQ2hK6IzkIhEcKxUSpSg-hp3iqcg_AtKMWEQYpjplKRE2adZEU5HSnEcqZjRuAl7LWM4qwg25AVSsaKQTjXSikbVo5KoJX7w6Xoao8rcrWWNU_hreSNZO-vHtz4G8b8JJpa-NyS2msyi5CYlXy1-sKlujFsOn_zrwM-yO2l05-Dbsf4J3ng_C18mcwc6iXObn8HaeLS-8ET8Dc3HrVw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endocrinology+and+metabolism+after+premature+pubarche+in+girls&rft.jtitle=Acta+P%C3%A6diatrica&rft.au=Lb%C3%A1%C3%B1ez%2C+L&rft.au=Potau%2C+N&rft.au=Zegher%2C+F+De&rft.date=1999-12-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0803-5253&rft.eissn=1651-2227&rft.volume=88&rft.spage=73&rft.epage=77&rft_id=info:doi/10.1111%2Fj.1651-2227.1999.tb14407.x&rft.externalDBID=10.1111%252Fj.1651-2227.1999.tb14407.x&rft.externalDocID=APA73
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0803-5253&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0803-5253&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0803-5253&client=summon